Evidence map›Paper›PMID 30943248›Full record

Trial reportPloS one2019

Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain.

Miguel Sola, Carmen Sanchez-Quevedo, Miguel A Martin-Piedra, Victor Carriel, Ingrid Garzon, Jesus Chato-Astrain, Oscar-Dario Garcia-Garcia, Miguel Alaminos, Fernando Campos

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miguel SolaFamily Medicine Unit, School of Medicine, University of Granada, Granada, Spain.ORCID 0000-0003-3179-7633
Carmen Sanchez-QuevedoInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Miguel A Martin-PiedraInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Victor CarrielInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.ORCID 0000-0002-8114-5644
Ingrid GarzonInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Jesus Chato-AstrainInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Oscar-Dario Garcia-GarciaInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Miguel AlaminosInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Fernando CamposInstituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvanced therapies are increasingly demanded by patients with the intent of treating some incurable conditions. Because family medicine professionals play an important role as health educators, their residency programs should incorporate new knowledge related to advanced therapies. To successfully implement these programs, how family medicine residents perceive these therapies should be investigated. The main components of perception, i.e. conceptual, procedural and attitudinal, refer to knowledge, skills and feelings, respectively. METHODS AND

findingsWe designed a specific questionnaire to assess the components of perceptions of advanced therapies in 300 medical residents enrolled in the Spanish National Family Medicine Residency Program. Each component consisted of 4 or 5 topics and each topic contained 6 items. Respondents scored highest in the procedural component (average 4.12±1.00), followed by the attitudinal (3.94±1.07) and conceptual component (3.04±1.43). Differences among the three components were statistically significant (p<0.00017). Family medicine residents perceived that procedures to implement advanced therapies are well established, especially their application. However, they felt their cognitive background was insufficient to respond efficiently to the expectations generated by these new therapeutic tools, especially in the regulatory framework. High awareness of the risks and limitations of these treatments was reflected by residents' preference for clinically tested therapies. Although they appropriately situated treatment with these therapies within hospital care, they associated the biofabrication of novel products with research centers, although these therapeutic tools can be produced in different facilities.

conclusionsThese results are potentially useful for designing future training programs and health policies for family medicine residents, and suggest the need to implement specific training programs in advanced therapies at the conceptual, procedural and attitudinal level.

Indexed as

AwarenessCurriculumInternship and ResidencySurveys and QuestionnairesAdultFamily PracticeFemaleHumansMaleSpain

Identifiers

PMID30943248
PMCPMC6447282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.